pubmed-article:15350444 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C0376387 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C0072980 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C0079189 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C0205174 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C1979963 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
pubmed-article:15350444 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:15350444 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:15350444 | pubmed:dateCreated | 2004-9-7 | lld:pubmed |
pubmed-article:15350444 | pubmed:abstractText | The aim of this study was to explore differences in the cytokine profile among de novo kidney transplant recipients treated with either Rapamycin (Rapa) + cyclosporine (CsA) + prednisone (P) or CsA + azathioprine (Aza) + P. | lld:pubmed |
pubmed-article:15350444 | pubmed:language | eng | lld:pubmed |
pubmed-article:15350444 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15350444 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15350444 | pubmed:issn | 0041-1345 | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:LlorenteLL | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:AlberúJJ | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:Correa-Rotter... | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:de LeoCC | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:Richaud-Patin... | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:Morales-Buenr... | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:Soto-VegaEE | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:Díaz-Alderete... | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:Vázquez-Lavis... | lld:pubmed |
pubmed-article:15350444 | pubmed:author | pubmed-author:CotoSS | lld:pubmed |
pubmed-article:15350444 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15350444 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:15350444 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15350444 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15350444 | pubmed:pagination | 1661-3 | lld:pubmed |
pubmed-article:15350444 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:meshHeading | pubmed-meshheading:15350444... | lld:pubmed |
pubmed-article:15350444 | pubmed:articleTitle | Effect of rapamycin on cytokine profile in kidney transplant recipients treated with triple drug therapy. | lld:pubmed |
pubmed-article:15350444 | pubmed:affiliation | Departments of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. | lld:pubmed |
pubmed-article:15350444 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15350444 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |